Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722041 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Sales Force Strategies in Oncology
Datamonitor, Jan 2002


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The sales force structures and strategies within a pharmaceutical company are vital components in ensuring maximized sales potential within the constraints of the company’s financial resources. As the pressures of an increasingly competitive market impact on the revenues attained by pharmaceutical companies, the relative expense in maintaining a sales force is continually increasing. By developing the most effective sales force structures and strategies, pharmaceutical companies can significantly enhance return on investment (ROI). Two key perspectives govern different strategies within the industry: * the business model of the company * the country targeted by the sales and marketed campaign. With this in mind, this brief analyses key sales force structures and strategies employed by: * large US-based ethical pharmaceutical companies * Japanese pharmaceutical companies * US-based biotechnology companies. For each classification, the inherent strengths and weaknesses revealed will be supported by in-depth case study analysis with reference to marketed oncology products and the strategies employed in their promotion. In doing so, this brief details sales force numbers, regional variations in strategy and the use of new technologies. This brief provides up-to-date information underpinning the success of current oncology products, in order to help you in your sales force strategy.


Customers who bought this item also bought

Sales Force Structures and Strategies 2001: A Case Study Analysis of Effective Sales Force Management

Pharmaceutical Sales Forces: Benchmarking sales force management by geographical market and product lifecycle

Br. Holdings Corporation

Br Malls Participacoes Sa

The Pharmaceutical Sales Force Outlook: Structures And Strategies To Maximize ROI And Boost Product Uptake

Sales Force Effectiveness

Chinese Markets for Polybutadiene Rubber (BR)

Pharmaceutical Sales Force Effectiveness Strategies: Evaluating Evolving Sales Models & Advanced Technology for a Customer Centric Approach

Improving Sales Force Effectiveness: Evaluating the ROI of technology solutions in the pharmaceutical industry

BR HOLDINGS - World'Vest Base Dossier

Biotechnology Company Growth Strategies

Pharmaceutical Sales Force Strategies: Driving ROI Through Best Practice In Targeting, Management, Outsourcing And Technologies



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds